These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17604166

  • 1. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
    Carta A, Palomba M, Paglietti G, Molicotti P, Paglietti B, Cannas S, Zanetti S.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4791-4. PubMed ID: 17604166
    [Abstract] [Full Text] [Related]

  • 2. Ring-substituted imidazoles as a new class of anti-tuberculosis agents.
    Gupta P, Hameed S, Jain R.
    Eur J Med Chem; 2004 Sep 01; 39(9):805-14. PubMed ID: 15337293
    [Abstract] [Full Text] [Related]

  • 3. Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
    Del Olmo E, Molina-Salinas GM, Escarcena R, Alves M, López-Pérez JL, Hernandez-Pando R, Said-Fernández S, Feliciano AS.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5764-8. PubMed ID: 19703769
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and anti-mycobacterial activities of triazoloquinolones.
    Carta A, Palomba M, Briguglio I, Corona P, Piras S, Jabes D, Guglierame P, Molicotti P, Zanetti S.
    Eur J Med Chem; 2011 Jan 01; 46(1):320-6. PubMed ID: 21145625
    [Abstract] [Full Text] [Related]

  • 5. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Jan 01; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 6. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
    Manvar A, Bavishi A, Radadiya A, Patel J, Vora V, Dodia N, Rawal K, Shah A.
    Bioorg Med Chem Lett; 2011 Aug 15; 21(16):4728-31. PubMed ID: 21752642
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z, Uzun M.
    Int J Antimicrob Agents; 2005 Jul 15; 26(1):78-80. PubMed ID: 15950439
    [Abstract] [Full Text] [Related]

  • 8. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M, Ruiz P, Herreras A.
    Int J Tuberc Lung Dis; 2000 Jun 15; 4(6):588-91. PubMed ID: 10864193
    [Abstract] [Full Text] [Related]

  • 9. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S, Jain M, Jain R, Kaur S, Singh PP.
    Bioorg Med Chem; 2004 May 15; 12(10):2501-8. PubMed ID: 15110831
    [Abstract] [Full Text] [Related]

  • 10. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A, Palchykovska LH, Kostina VH, Sanna A, Meleddu R, Chisu L, Alexeeva IV, Shved AD.
    Int J Antimicrob Agents; 2009 Mar 15; 33(3):223-9. PubMed ID: 19070992
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives.
    Ghosh S, Tiwari P, Pandey S, Misra AK, Chaturvedi V, Gaikwad A, Bhatnagar S, Sinha S.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4002-5. PubMed ID: 18579372
    [Abstract] [Full Text] [Related]

  • 12. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T, Herbert D, Venkatesan P, Paramasivan CN.
    Int J Lepr Other Mycobact Dis; 1997 Sep 15; 65(3):375-8. PubMed ID: 9401493
    [Abstract] [Full Text] [Related]

  • 13. N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
    Sriram D, Yogeeswari P, Dhakla P, Senthilkumar P, Banerjee D.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):1888-91. PubMed ID: 17276683
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov 01; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 15. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M, Senthilkumar P, Yogeeswari P, Sriram D.
    Biomed Pharmacother; 2009 Jan 01; 63(1):11-8. PubMed ID: 18078735
    [Abstract] [Full Text] [Related]

  • 16. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z, Sharma S, Khuller GK, Singh P, Faujdar J, Katoch VM.
    Int J Antimicrob Agents; 2006 Dec 01; 28(6):543-4. PubMed ID: 17101262
    [Abstract] [Full Text] [Related]

  • 17. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM, El-Koussi NA, Hassan HY.
    Arch Pharm (Weinheim); 2009 Feb 01; 342(2):94-9. PubMed ID: 19173243
    [Abstract] [Full Text] [Related]

  • 18. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases.
    Camacho-Corona Mdel R, Ramírez-Cabrera MA, Santiago OG, Garza-González E, Palacios Ide P, Luna-Herrera J.
    Phytother Res; 2008 Jan 01; 22(1):82-5. PubMed ID: 17726732
    [Abstract] [Full Text] [Related]

  • 19. A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives.
    Aridoss G, Amirthaganesan S, Kumar NA, Kim JT, Lim KT, Kabilan S, Jeong YT.
    Bioorg Med Chem Lett; 2008 Dec 15; 18(24):6542-8. PubMed ID: 18952418
    [Abstract] [Full Text] [Related]

  • 20. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A, Rigouts L, Shamputa IC, Dediste A, Struelens M, Portaels F.
    Int J Infect Dis; 2008 Mar 15; 12(2):152-6. PubMed ID: 17950021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.